We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

124 hedge funds and large institutions have $301M invested in Lifecore Biomedical in 2013 Q2 according to their latest regulatory filings, with 124 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less call options, than puts

Call options by funds: $7K | Put options by funds: $267K

Holders
124
Holders Change
+124
Holders Change %
–
% of All Funds
4.05%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
124
Increased
–
Reduced
–
Closed
–
Calls
$7K
Puts
$267K
Net Calls
-$260K
Net Calls Change
-$260K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
1
Guggenheim Capital
Illinois
$29.7M +$31.1M +2,249,571 New
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$28.2M +$29.5M +2,135,252 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$23.3M +$24.4M +1,761,390 New
WC
4
Wynnefield Capital
New York
$22.9M +$24.9M +1,802,801 New
KG
5
Killen Group
Pennsylvania
$17.3M +$18.1M +1,308,027 New
OCG
6
Opus Capital Group
Ohio
$12.4M +$13M +936,558 New
BIT
7
BlackRock Institutional Trust
California
$10.6M +$11.1M +800,939 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$8.81M +$9.22M +666,610 New
BFA
9
BlackRock Fund Advisors
California
$8.54M +$8.94M +646,308 New
AI
10
Ariel Investments
Illinois
$7.91M +$8.28M +598,499 New
OSAM
11
O'Shaughnessy Asset Management
Connecticut
$7.25M +$7.58M +548,055 New
State Street
12
State Street
Massachusetts
$6.66M +$6.97M +503,716 New
Bank of America
13
Bank of America
North Carolina
$6.26M +$6.55M +473,578 New
PCM
14
Perritt Capital Management
Illinois
$5.49M +$5.75M +415,550 New
Northern Trust
15
Northern Trust
Illinois
$5.04M +$5.28M +381,826 New
BCM
16
Bridgeway Capital Management
Texas
$4.71M +$4.93M +356,200 New
Allianz Asset Management
17
Allianz Asset Management
Germany
$4.37M +$4.57M +330,615 New
CS
18
Credit Suisse
Switzerland
$3.89M +$4.07M +294,258 New
TBAM
19
True Bearing Asset Management
California
$3.72M +$3.9M +281,809 New
SFM
20
Systematic Financial Management
New Jersey
$3.51M +$3.67M +265,550 New
TAM
21
THB Asset Management
Connecticut
$3.24M +$3.4M +245,572 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$3.19M +$3.34M +241,443 New
Macquarie Group
23
Macquarie Group
Australia
$3.13M +$3.28M +237,153 New
QBFM
24
QS Batterymarch Financial Management
New York
$3.07M +$3.21M +232,140 New
Renaissance Technologies
25
Renaissance Technologies
New York
$2.95M +$3.09M +223,600 New
1
2 3 4 5

LFCR Hedge Fund Activity: Q2 2013 in Review

124 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2013, worth a combined $301M.

Buyers outnumbered sellers: 124 funds opened new LFCR positions and 0 closed out — a net gain of 124 holders — while 0 added to existing stakes and 0 trimmed.

  • 124 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $301M of Lifecore Biomedical stock for Q2 2013.
  • 124 funds opened new Lifecore Biomedical positions in Q2 2013 and 0 closed out, a net change of +124 holders.

Based on aggregated 13F filings for Q2 2013.